Jim Cramer advised investors to avoid Danaher Corporation, calling the stock a huge disappointment during a recent Mad Money episode. Responding to a caller, Cramer said he does not want anyone near Danaher, though he acknowledged it could go higher and has a good chart. He noted the company trades at 21 times earnings but is only posting 4 to 6% organic growth, making it overvalued at current prices. Cramer contrasted Danaher with Thermo Fisher, which trades at less than 20 times earnings but has a 1% organic growth rate.
Danaher CorporationCramer calls Danaher overvalued at 21x earnings with only 4-6% organic growth, advising to avoid.
Thermo Fisher Scientific Inc